BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 15220194)

  • 1. Glucose- and interleukin-1beta-induced beta-cell apoptosis requires Ca2+ influx and extracellular signal-regulated kinase (ERK) 1/2 activation and is prevented by a sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (SUR/Kir6.2) selective potassium channel opener in human islets.
    Maedler K; Størling J; Sturis J; Zuellig RA; Spinas GA; Arkhammar PO; Mandrup-Poulsen T; Donath MY
    Diabetes; 2004 Jul; 53(7):1706-13. PubMed ID: 15220194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and selective activation of the pancreatic beta-cell type K(ATP) channel by two novel diazoxide analogues.
    Dabrowski M; Larsen T; Ashcroft FM; Bondo Hansen J; Wahl P
    Diabetologia; 2003 Oct; 46(10):1375-82. PubMed ID: 12961066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose.
    Ritzel RA; Hansen JB; Veldhuis JD; Butler PC
    J Clin Endocrinol Metab; 2004 Feb; 89(2):795-805. PubMed ID: 14764798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener, in healthy male subjects.
    Zdravkovic M; Kruse M; Rost KL; Møss J; Kecskes A; Dyrberg T
    J Clin Pharmacol; 2005 Jul; 45(7):763-72. PubMed ID: 15951466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat.
    Carr RD; Brand CL; Bodvarsdottir TB; Hansen JB; Sturis J
    Diabetes; 2003 Oct; 52(10):2513-8. PubMed ID: 14514634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirements of calcium fluxes and ERK kinase activation for glucose- and interleukin-1beta-induced beta-cell apoptosis.
    Fei H; Zhao B; Zhao S; Wang Q
    Mol Cell Biochem; 2008 Aug; 315(1-2):75-84. PubMed ID: 18498041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of hyperinsulinemia by NN414, a SUR1/Kir6.2 selective K-adenosine triphosphate channel opener, improves glucose tolerance and lipid profile in obese Zucker rats.
    Alemzadeh R; Fledelius C; Bodvarsdottir T; Sturis J
    Metabolism; 2004 Apr; 53(4):441-7. PubMed ID: 15045689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K(+) channel opener?
    Fan X; Ding Y; Cheng H; Gram DX; Sherwin RS; McCrimmon RJ
    Diabetes; 2008 Dec; 57(12):3327-34. PubMed ID: 18776135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
    Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
    J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible New Strategies for the Treatment of Congenital Hyperinsulinism.
    Sikimic J; Hoffmeister T; Gresch A; Kaiser J; Barthlen W; Wolke C; Wieland I; Lendeckel U; Krippeit-Drews P; Düfer M; Drews G
    Front Endocrinol (Lausanne); 2020; 11():545638. PubMed ID: 33193079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards selective Kir6.2/SUR1 potassium channel openers, medicinal chemistry and therapeutic perspectives.
    Hansen JB
    Curr Med Chem; 2006; 13(4):361-76. PubMed ID: 16475928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta-cells.
    Koriyama N; Kakei M; Nakazaki M; Yaekura K; Ichinari K; Gong Q; Morimitsu S; Yada T; Tei C
    Diabetes; 2000 Nov; 49(11):1830-9. PubMed ID: 11078449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
    Thams P; Anwar MR; Capito K
    Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of rat pancreatic islets by potassium channel openers against alloxan, sodium nitroprusside and interleukin-1beta mediated suppression--possible involvement of the mitochondrial membrane potential.
    Kullin M; Li Z; Bondo Hansen J; Welsh N; Karlsson FA; Sandler S
    Diabetologia; 2003 Jan; 46(1):80-8. PubMed ID: 12637986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue specificity of sulfonylureas: studies on cloned cardiac and beta-cell K(ATP) channels.
    Gribble FM; Tucker SJ; Seino S; Ashcroft FM
    Diabetes; 1998 Sep; 47(9):1412-8. PubMed ID: 9726229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both triggering and amplifying pathways contribute to fuel-induced insulin secretion in the absence of sulfonylurea receptor-1 in pancreatic beta-cells.
    Nenquin M; Szollosi A; Aguilar-Bryan L; Bryan J; Henquin JC
    J Biol Chem; 2004 Jul; 279(31):32316-24. PubMed ID: 15175349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.
    Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S
    Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of NN414, a SUR1/Kir6.2 selective potassium channel opener in subjects with type 2 diabetes.
    Zdravkovic M; Kruse M; Rost KL; Møss J; Kecskes A
    Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):405-6. PubMed ID: 17701889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulated expression of adenosine triphosphate-sensitive potassium channel subunits in pancreatic beta-cells.
    Moritz W; Leech CA; Ferrer J; Habener JF
    Endocrinology; 2001 Jan; 142(1):129-38. PubMed ID: 11145575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.